Average Co-Inventor Count = 8.67
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Pharma Aktiengesellschaft (14 from 378 patents)
2. Bayer Schering Pharma Ag (7 from 192 patents)
3. Harvard College (6 from 2,963 patents)
4. The General Hospital Corporation (6 from 2,893 patents)
5. The Broad Institute, Inc. (6 from 443 patents)
6. Bayer Aktiengesellschaft (5 from 12,160 patents)
7. Schering Aktiengesellschaft (3 from 1,384 patents)
8. Bayer Intellectual Property Gmbh (3 from 721 patents)
9. Bayer Aktiengellschaft (1 from 5 patents)
10. Bayer Pharma Aktiengellschaft (1 from 1 patent)
11. Bayer Pharma Aktiegellschaft (1 from 1 patent)
12. Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts (119 patents)
29 patents:
1. 12486248 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH
2. 11787797 - 4,5-annulated 1,2,4-triazolones
3. 11713304 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH
4. 11130745 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH
5. 10968216 - 4,5-annulated 1,2,4-triazolones
6. 10919862 - Fused imidazoles as mIDH1 inhibitors
7. 10815215 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH
8. 10442772 - Benzimidazol-2-amines as mIDH1 inhibitors
9. 10137110 - 1-cyclohexyl-2-phenylaminobenzimidazoles as mIDH1 inhibitors for the treatment of tumors
10. 9957235 - Benzimidazol-2-amines as mIDH1 inhibitors
11. 9951027 - Benzimidazol-2-amines as MIDH1 inhibitors
12. 9468642 - Imidazopyrazines
13. 9428460 - [object Object]
14. 9388140 - Substituted benzimidazoles
15. 9340528 - Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors